Matthew Christopher is an accomplished researcher specializing in chemical biology, currently serving as a Principal Investigator at both Covant Therapeutics since September 2022 and Roivant Sciences since October 2021. Prior to these roles, Matthew held the position of Senior Scientist in Chemical Biology and Chemist at Merck from July 2007 to December 2021. Matthew earned a Bachelor of Arts in Chemistry from Boston University, completing the degree in 2007.
This person is not in the org chart
This person is not in any teams
This person is not in any offices